Table 1.
Parameter | Training and validation cohort (n = 15,635 patients, n = 25,529 DICOM) |
Test cohort (n = 111 studies) |
---|---|---|
Clinical data | ||
Age, years, mean (IQR) | 70.7 (60–83) | 77.4 (69–90) |
Gender, male, % | 48 | 51 |
Race, % | ||
White | 51 | 53 |
Black | 31 | 27 |
Other | 18 | 20 |
Height, cm, mean (IQR) | 170 (163–178) | 170 (163–178) |
Weight, kg, mean (IQR) | 79 (67–93) | 81 (69–97) |
Systolic blood pressure, mm Hg | 130 ± 23 | 126 ± 25 |
Diastolic blood pressure, mm Hg | 72 ± 15 | 68 ± 12 |
Echocardiographic data, cm | ||
IVSd | 1.01 | 1.04 |
PWd | 1.00 | 1.04 |
LVIDd | 5.06 | 5.04 |
EF (Biplane method of disks), % | 52.22 | 39.6 |
Wall motion abnormality, n (%) | ||
Inferior | 5,705 (22) | 48 (43) |
Inferolateral | 4,681 (18) | 46 (41) |
Anterolateral | 3,352 (13) | 43 (39) |
Anterior | 4,495 (18) | 46 (41) |
Anteroseptal | 2,508 (10) | 34 (31) |
Inferoseptal | 4,221 (17) | 42 (38) |
Apical | 5,745 (23) | 52 (47) |
Any RWMA | 10,722 (42) | 66 (59) |
A subset of measurements is available for the test cohort. EF, Left ventricular ejection fraction; IQR, interquartile range; IVSd, interventricular septal thickness; LVIDd, left ventricular end-diastolic diameter; PWd, posterior wall thickness.